News and Announcements
Bhumi’s equity crowdfunding campaign launches on Monday, 25 February 2019
- Published March 10, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Highlights
- Bhumi is launching an equity crowdfunding campaign with Birchal
- The campaign will begin on Monday, 25 February and be open for two weeks
Toxic dyes, pesticides, child labour and sweatshops should have no place in textiles today. At Bhumi, we believe every product must be made with respect for the human and environmental resources that make it possible.
Bhumi was founded to offer sustainable Bedding, Bath and Basics that are made with the greater good in mind. Our supply chain is endorsed by Fairtrade, all the cotton used is certified organic and our processes are sustainable from “seed to shelf”.
Since 2015, by choosing organic cotton over regular cotton, Bhumi has saved 60 million litres of water, avoided 294,507 km of driving emissions and powered 102 million light bulbs through energy savings, along with ZERO toxic chemicals & NO child labour.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
